A Minnesota federal judge added three years of probation to a $296 million plea deal between Guidant Corp. and the U.S. Justice Dept. over faulty implantable defibrillators.
Last spring, Judge Donovan Frank spiked a $296 million agreement involving a guilty plea by the now-Boston Scientific Corp. (NYSE:BSX) subsidiary, saying the deal didn’t go far enough to address Guidant’s penchant for concealing problems with the devices.